JOY WILCOX: Open Payments
NPI 1962635359 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 23 payments from 13 companies in 2025. Trend: 2023 $1,780 · 2024 $972 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $293 |
| Actelion Pharmaceuticals US, Inc. | 3 | $76 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Philips North America LLC | 2 | $42 |
| GENZYME CORPORATION | 2 | $36 |
| Viatris Specialty LLC | 2 | $33 |
| Grifols USA, LLC | 1 | $25 |
| Verona Pharma, Inc. | 1 | $24 |
| Insmed, Inc. | 1 | $24 |
Products named: TREMFYA, DUPIXENT, NUCALA, XIFAXAN, UPTRAVI, Vest Therapy Und, YUPELRI, OPSUMIT.
Industry payments across AR — which companies pay providers there.
